In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



This article was originally published in The Gray Sheet

Executive Summary

Licenses from Medtronic a patent covering a "defibrillation lead system and method of use," Incontrol announces. In exchange for the non-exclusive worldwide license, Medtronic will receive royalties on sales of InControl's Perimeter defibrillation lead systems, which are intended for use with the firm's Metrix atrial defibrillators. "This license agreement resolves any issues in connection with InControl's use of the technology covered in this patent and permits InControl to use this shocking vector in any cardiac device it may make, use, or sell," InControl says



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts